Neftaly: Strategies for Building Local Capacity for Biomarker Technology
Biomarker technologies are transforming the way diseases are diagnosed, monitored, and managed. However, for these technologies to have a meaningful and lasting impact—especially in low- and middle-income countries—local capacity must be built to ensure ownership, sustainability, and self-reliance. Neftaly is committed to empowering communities and health systems through targeted, practical strategies to localize and scale biomarker innovation.
Why Local Capacity Matters
- Ensures long-term sustainability of biomarker programs
- Reduces dependency on external expertise and imports
- Improves responsiveness to local health needs and disease patterns
- Promotes innovation rooted in local knowledge and context
- Strengthens public health systems through self-managed diagnostic capabilities
Neftaly’s Key Strategies for Building Local Capacity
1. Skills Development and Training
Neftaly invests in building a skilled workforce through:
- Hands-on workshops in biomarker testing, lab operations, and quality control
- Online and in-person courses for laboratory professionals, data managers, and clinicians
- “Train-the-trainer” models to create local hubs of expertise and mentorship
2. Strengthening Laboratory Infrastructure
We support the development and enhancement of diagnostic labs by:
- Providing equipment, reagents, and supplies adapted to local conditions
- Establishing basic laboratory protocols for biomarker collection and analysis
- Supporting lab accreditation and biosafety standards compliance
3. Technology Transfer and Localization
Neftaly works with local partners to:
- Adapt biomarker platforms to fit local resource constraints
- Support in-country production or assembly of test kits and devices
- Promote open-source technologies and fair licensing for scalability
4. Research and Innovation Support
We encourage home-grown innovation by:
- Partnering with universities and research centers for collaborative biomarker studies
- Providing technical and financial support for local pilot projects
- Creating opportunities for young scientists to engage in translational research
5. Digital Infrastructure and Data Management
Neftaly enables better biomarker data use by:
- Developing digital tools to record, analyze, and visualize biomarker data
- Training local staff in secure data handling and interpretation
- Integrating biomarker data into national health information systems
6. Policy and Regulatory Engagement
We assist governments and institutions in:
- Developing guidelines and policies for biomarker use and approval
- Ensuring ethical frameworks for testing, data privacy, and consent
- Building national strategies that include biomarker technology in public health planning
7. Community Awareness and Acceptance
Neftaly involves local communities through:
- Health education campaigns to build trust and understanding of biomarker testing
- Culturally sensitive outreach to increase participation in testing and surveillance
- Inclusion of community leaders in planning and oversight processes
Real-World Impact
In several Neftaly-supported regions, local labs now perform biomarker-based diagnostics that were previously outsourced to international facilities. As a result:
- Diagnosis times have dropped significantly
- Cost savings have improved access for low-income patients
- Local scientists have developed their own biomarker research programs
Conclusion
Building local capacity for biomarker technology is essential for equitable health innovation. At Neftaly, we believe that true progress comes when communities are equipped to lead their own diagnostic and research efforts. Through training, infrastructure development, and inclusive collaboration, we help create resilient health systems that can deliver precision care—today and in the future.